A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction

REFERENCES

• Brown , R L , Papasouliotis , O , Patterson , J J and Rounds , L A . 1996 . Substance abuse among patients with chronic back pain . J Fam Pract , 43 : 152 – 60 .
   PubMed Web of Science ®Google Scholar
• Reid , M C , Engles-Horton , L L , Weber , M B , Kerns , R D , Rogers , E L and O’Connor , P G . 2002 . Use of opioid medications for chronic noncancer pain syndromes in primary care . J Gen Intern Med , 17 : 173 – 9 .
   PubMed Web of Science ®Google Scholar
• Breckenridge , J and Clark , J D . 2003 . Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain . J Pain , 4 : 344 – 50 .
   PubMed Web of Science ®Google Scholar
• Mahowald , M L , Singh , J A and Majeski , P . 2005 . Opioid use by patients in an orthopedics spine clinic . Arthritis Rheum , 52 : 312 – 21 .
   PubMed Web of Science ®Google Scholar
• Martell , B A , O’Connor , P G Kerns , R D . 2007 . Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction . Ann Intern Med , 146 ( 2 ) : 116 – 27 .
   PubMed Web of Science ®Google Scholar
• Cowan , D T , Wilson-Barnett , J , Griffiths , P and Allan , L G . 2003 . A survey of chronic noncancer pain patients prescribed opioid analgesics . Pain Med , 4 ( 4 ) : 340 – 51 .
   PubMed Web of Science ®Google Scholar
• Chu , L F , Clark , D J and Angst , M S . 2006 . Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study . J Pain , 7 : 43 – 8 .
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services . 2005 . “ Medication-assisted treatment for opioid addiction in opioid treatment programs. A treatment Improvement Protocol (TIP) 43. (DHHS Publication No. (SMA) 05-4048) ” . Rockville, MD : Substance Abuse and Mental Health Services Administration .
   Google Scholar
• Veterans Health Administration, Department of Defense . VA/DoD clinical practice guideline for the management of opioid therapy for chronic pain . Washington, DC, 2010. Retrieved from http://www.guideline.gov/content.aspx?id=16313. (ac- cessed February 11, 2013)
   Google Scholar
• Blondell , R D and Ashrafioun , L . 2008 . Treating opioid dependency and coexistent chronic nonmalignant pain . Am Fam Physician , 78 : 1132 – 3 .
   PubMed Web of Science ®Google Scholar
• Jackman , R , Purvis , J M and Mallett , B S . 2008 . Chronic nonmalignant pain in primary care . Am Fam Physician , 78 : 1155 – 62 .
   PubMed Web of Science ®Google Scholar
• Last , A R and Hulbert , K . 2009 . Chronic low back pain: evaluation and management . Am Fam Physician , 79 ( 12 ) : 1067 – 74 .
   PubMed Web of Science ®Google Scholar
• Blondell , R D , Ashrafioun , L , Dambra , C M , Foschio , E M , Zielinski , A L and Salcedo , D M . 2010 . A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and coexistent opioid addiction . J Addict Med , 4 ( 3 ) : 140 – 6 .
   PubMed Web of Science ®Google Scholar
• Savage , S R . 2003 . “ Opioid medications in the management of pain ” . In Principles of addiction medicine , Edited by: Graham , A W , Schultz , T K , Mayo-Smith , M F , Ries , R K and Wilford , B B . 1451 – 63 . Chevy Chase , MD : American Society of Addiction Medicine .
   Google Scholar
• Carpenter , K J , Chapman , V and Dickenson , A H . 2000 . Neuronal inhibitory effects of methadone are predominantly opioid receptor mediated in the rat spinal cord in vivo . Eur J Pain , 4 : 19 – 26 .
   PubMed Web of Science ®Google Scholar
• Resine , T and Pasternak , G . 2001 . “ Opioid analgesics and antagonists ” . Edited by: Hardman , J G , Limbird , L E and Gilman , A G . 521 – 55 . New York, NY : McGraw-Hill . The pharmacological basis of therapeutics. 10th ed.
   Google Scholar
• Altier , N , Dion , D , Boulanger , A and Choinière , M . 2005 . Management of neuropathic pain with methadone: a review of 13 cases . Clin J Pain , 21 ( 4 ) : 364 – 9 .
   PubMed Web of Science ®Google Scholar
• Doverty , M , White , J M , Somogyi , A A , Bochner , F , Ali , R and Ling , W . 2001 . Hyperalgesic responses in methadone maintenance patients . Pain , 90 : 91 – 6 .
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services . 2012 . “ Managing chronic pain in adults with or in recovery from substance use disorders. A treatment Improvement Protocol (TIP) 45. (DHHS Publication No. (SMA) 12-4671) ” . Rockville, MD : Substance Abuse and Mental Health Services Administration .
   Google Scholar
• Rhodin , A , Grönbladh , L , Nilsson , L H and Gordh , T . 2006 . Methadone treatment of chronic non-malignant pain and opioid dependence: a long-term follow-up . Eur J Pain , 10 ( 3 ) : 271 – 8 .
   PubMed Web of Science ®Google Scholar
• Kosten , T R , Schottenfeld , R , Ziedonis , D and Falcioni , J . 1993 . Buprenorphine versus methadone maintenance for opioid dependence . J Nerv Ment Dis , 181 ( 6 ) : 358 – 64 .
   PubMed Web of Science ®Google Scholar
• Barnett , P G , Rodgers , J H and Bloch , D A . 2001 . A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence . Addict , 96 : 683 – 90 .
   PubMed Web of Science ®Google Scholar
• Bridge , T P , Fudala , P J , Herbert , S and Leiderman , D B . 2003 . Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence . Drug Alcohol Depend , 70 ( 2 Suppl ) : S79 – 85 .
   PubMed Web of Science ®Google Scholar
• Kakko , J , Svanborg , K D , Kreek , M J and Heilig , M . 2003 . 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial . Lancet , 361 ( 9358 ) : 662 – 8 .
   PubMed Web of Science ®Google Scholar
• Mattick , R P , Kimber , J , Breen , C and Davoli , M . 2008 . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence . Cochrane Database of Systematic Rev , 1 : CD002207
   Google Scholar
• Woody , G E , Poole , S A Subramaniam , G . 2008 . Extended vs Short-term buprenorphine naloxone for treatment of opioid-addicted youth: a randomized trial . JAMA , 300 ( 17 ) : 2003
   PubMed Web of Science ®Google Scholar
• Walsh , S L , Preston , K L , Bigelow , G E and Stitzer , M L . 1995 . Acute administration of buprenorphine in humans: partial agonist and blockade effects . J Pharmacol Expl Ther , 274 : 361 – 72 .
   PubMed Web of Science ®Google Scholar
• Tennant , F S Jr. and Rawson , R A . 1982 . Outpatient treatment of prescription opioid dependence: comparison of two methods . Arch Int Med , 142 : 1845 – 7 .
   PubMed Web of Science ®Google Scholar
• Kennedy , J A and Crowley , T J . 1990 . Chronic pain and substance abuse: a pilot study of opioid maintenance . JSAT , 7 : 233 – 8 .
   Google Scholar
• American Psychiatric Association . 2000 . Diagnostic and statistical manual of mental disorders: DSM-IV-TR , Washington , DC : American Psychiatric Press .
   Google Scholar
• Malinoff , H L , Barkin , R L and Wilson , G . 2005 . Sublingual buprenorphine is effective in the treatment of chronic pain syndrome . Am J Ther , 12 : 379 – 84 .
   PubMedGoogle Scholar
• Suboxone [package insert] . 2010 . Richmond , VA : Reckitt Benckiser Pharmaceuticals, Inc .
   Google Scholar
• Dolophine [package insert] . 2006 . Columbus , OH : Roxane Laboratories, Inc .
   Google Scholar
• Wessen , D R and Ling , W . 2003 . The clinical opiate withdrawal score (COWS) . J Psychoactive Drugs , 35 : 253 – 9 .
   PubMed Web of Science ®Google Scholar
• Schottenfeld , R S , Pakes , J R , Oliveto , A , Ziedonis , D and Kosten , T R . 1997 . Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse . Arch Gen Psychiatry , 54 ( 8 ) : 713 – 20 .
   PubMed Web of Science ®Google Scholar
• Sullivan , L E , Moore , B A O’Connor , P G . 2009 . The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence . Am J Addict , 19 : 53 – 8 .
   Web of Science ®Google Scholar